期刊文献+

PEI-壳聚糖在结肠癌细胞CD133^+梯度表达的转染研究 被引量:1

Transfection Efficiency Using PEI-CP Complex for CD133^+ Differently Expressed by Colon Cancer Lines
原文传递
导出
摘要 目的:以PEI-壳聚糖(CP)为载体材料,考察CD133^+呈梯度表达的4种结肠癌细胞上的转染效率,将特异性结合CD133的TR多肽修饰CP材料,探讨材料与转染的关系。方法:根据CD133^+含量将细胞分为高表达组和低表达组,合成法制备CP材料,激光粒度仪测定纳米粒粒径、电位,CCK8实验检测细胞毒性,用质粒p GL3和EGFP考察CP材料的转染效果,Western印记检测CD133^+蛋白的表达。结果:CD133^+高表达组SW480、HCT116的CD133^+含量为96.97%、92.96%,低表达组CaCO_2、SW620的CD133^+含量为2.00%、0.56%;CCK8结果得出,CP材料按质量比N/P=5时,生物安全性较高;质粒p GL3转染高表达组,其CD133^+RLU值低于低表达组;质粒EGFP转染高表达组,绿色荧光弱于低表达组,Western blot检测接TR肽的CP材料CD133^+表达高于CP材料。结论:CP材料在低表达CD133^+组转染效率高,且接TR肽的CP材料针对CD133^+有可能介导材料进入细胞。 Objective:To investigate transfect efficiency of CP/DNA at CSC marker CD133^+ which is shown to be differently expressed in colon cancer cell lines,and to discuss the relationship between transfect and TR peptide,which is capable to specifically bind to CD133 by targeting CD133^+ colon cancer cells.Methods:The expression of CD133^+ in four cell lines were divided into 2 groups:the positive colon cell lines in SW480,HCT116,and the negative in CaCO2,SW620.Considering of PEI and Chitosan,they were linked together and composition,particle size,as well as the zeta potential of CP complex was measured.CCK-8 assay was also used to evaluate their toxicity.Using Chitosan-linked-PEI as the vector,PGL3 and EGFP plasmid transfect into four colon cancer cells after 48 h incubation,and the CD133-related protein expressions were assessed by Western blotting analysis.Results:The CSC marker expression of CD133^+ were significantly different.CD133^+ was positive in more than 90% of colon cells,SW480 in 96.97%,HCT116 in 92.96%,however,low expression of CaCO2,SW620 was found in 2.00%,0.56%.When the N/P of PEI/Chitosan/DNA was 5∶ 4∶ 1,CP complex shows a high transfect efficiency and low toxicity.And when the positive expression of CD133^+ was added,the transfect efficiency was decreased.The result of Western blotting analysis showed that the ratios of CD133 in positive group were higher than those in negative group.Conclusion:The transfect efficiency of CP vector can increase the transfect efficient in low expression of CD133^+ .TR peptide-CD133 may facilitate CP vector into cells.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2016年第6期32-38,共7页 China Biotechnology
基金 国家青年自然科学基金(81202771)资助项目
关键词 非病毒载体 转染 结直肠癌 CD133^+ Non-viral vector Transfection Colon cancer CD133^+
  • 相关文献

参考文献21

  • 1Siegel R,Desantis C,Jemal A.Colorectal cancer statistics,2014.CA Cancer J Clin,2014,64(2):104-117.
  • 2陈万青,张思维,郑荣寿,曾红梅,邹小农,赵平,吴良有,李光琳,赫捷.中国2009年恶性肿瘤发病和死亡分析[J].中国肿瘤,2013,22(1):2-12. 被引量:448
  • 3王炜东,袁玉松,何嗪.结肠癌发生、发展与miRNA分子机制相关研究进展[J].中国生化药物杂志,2015,35(7):169-171. 被引量:19
  • 4Ong C W,Kim L G,Kong H H,et al.CD133 expression predicts for non-response to chemotherapy in colorectal cancer.Modern Pathology,2010,23(3):450-457.
  • 5Li C Y,Li B X,Liang Y,et al.Higher percentage of CD133+cells is associated with poor prognosis in colon carcinoma patients with stage IIIB.J Transl Med,2009,7:56.
  • 6Wang Q,Chen Z G,Du C Z,et al.Cancer stem cell marker CD133+tumor cells and clinical outcome in rectal cancer.Histopathology,2009,55(3):284-293.
  • 7Xi H Q,Zhao R.Clinicopathological significance and prognostic value of Eph A3 and CD133+expression in colorectal carcinoma.Journal of Clinical Pathology,2011,64(6):498-503.
  • 8Yasuda H,Tanana K,Salgusa S,et al.Elevated CD133 but not VEGF or EGFR,as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.Oncology Reports,2009,22(4):709-717.
  • 9Horst D,Scheel S K,Liebmann S,et al.The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.The Journal of Pathology,2009,219(4):427-434.
  • 10Arun K Iyer,Amit Singh,Mansoor M Amiji,et al.Role of integrated cancer nanomedicine in overcoming drug resistance.Advanced Drug Delivery Reviews,2013,65(3):1784-1802.

二级参考文献26

  • 1Gil J, Stembalska A, Pesz KA, et al. Cancer stem cells: the theory and perspectives in cancer therapy ~J~. J Appl Genet, 2008, 49(2): 193 -9.
  • 2Toren A, Bielorai B, Jacob Hirsch J, et al. CD133-positive hematopoietic stem cell "sternness" genes contain many genesmutated or abnormally expressed in leukemia [J]. Stem Ceils, 2005, 23(8): 1142-53.
  • 3Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell [Jl. Stem Cell Rev, 2008, 4(3): 193-201.
  • 4Singh SK, Clarke ID, TerasakiM, et al. Identification of a cancer stern cell in human brain tumors [J]. Cancer Res, 2003, 63(18): 5821-8.
  • 5Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells [J]. Blood, 1997, 90 (12): 5002-12.
  • 6Tirino V, Camerlingo R, Franco R, et al. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer [J]. Eur J Cardiothorac Surg, 2009, 36 (3): 446-53.
  • 7Rutella S, Bonanno G, Procoli A, et al. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors[J]. Clin Cancer Res, 2009, 15(13): 4299-311.
  • 8Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells [J]. Nature, 2007, 445(7123): 111-5.
  • 9Clarke MF, Fuller M. Stem cells and cancer: two faces of eve [J]. Cell, 2006, 124(6): 1111-5.
  • 10Zhu LQ Gibson P, Cuttle DS, et al. Promininl marks intestinal stern ceils that are susceptible toneoplastic transformation [J]. Nature, 2009, 457(7229): 603-7.

共引文献468

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部